Network Meta-Analysis of Different Intravenous Glucocorticoid Regimes for the Treatment of Graves' Orbitopathy
Background: Intravenous glucocorticoid (GC) has been proposed to treat moderately severe Graves' orbitopathy (GO); however, the optimal regime remains debatable. We therefore performed this network meta-analysis to objectively determine the comparative efficacy and safety of different intraveno...
Saved in:
Main Authors: | Jun Jia (Author), Jingjian Dong (Author), Lin Deng (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Success Treatment of Severe and Active Graves' Orbitopathy with Tocilizumab After Thyroidectomy and Maximum Dose of Intravenous Methylprednisolone
by: Laurentius Aswin Pramono
Published: (2023) -
IgG4 as a Biomarker in Graves' Orbitopathy
by: Michał Olejarz, et al.
Published: (2021) -
Evaluation of IL-29 in Euthyroid Patients with Graves' Orbitopathy: A Preliminary Study
by: Bogusz Falkowski, et al.
Published: (2020) -
Markers of Inflammation and Fibrosis in the Orbital Fat/Connective Tissue of Patients with Graves' Orbitopathy: Clinical Implications
by: Przemyslaw Pawlowski, et al.
Published: (2014) -
Percentage of Myeloid Dendritic Cells in Peripheral Venous Blood Is Negatively Related to Incidence of Graves' Orbitopathy
by: Katarzyna Wojciechowska-Durczynska, et al.
Published: (2021)